Indonesia Urges Greater Transparency in Cross-Border Copyright Royalty Governance Before 35 Countries 
SaunaKits.com Opens Its Upstate South Carolina Showroom, Bringing Hands-On Sauna Shopping to the Southeast 
Encore Construction Shares Guidance to Help Homeowners Avoid Costly Water Damage Insurance Claim Mistakes Virbac : Declaration of the number of shares and voting rights June 2021
DECLARATION OF THE NUMBER OF SHARES AND VOTING…
Trigone Pharma to Present Preclinical Data for TRG-100 in Interstitial Cystitis / Bladder Pain Syndrome at the Upcoming American Urological Association Conference (AUA) in September 2021
RAANANA, Israel, July 22, 2021 (GLOBE NEWSWIRE) — Trigone Pharma Ltd., a privately owned biopharmaceutical…
Gelteq Appoints Seasoned Pharma and Tech Executive, James Pekarsky, as Chief Financial Officer
MELBOURNE, Australia, July 22, 2021 (GLOBE NEWSWIRE) — Gelteq Pty Ltd, a global leader in…
Biosplice Publishes Phase 2B Lorecivivint Analysis Showing Clinically Meaningful Benefits to Knee Osteoarthritis Patients
Lorecivivint post-hoc analysis reveals significantly increased likelihood of symptom improvements for knee osteoarthritis compared to…
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Daix (France), July 22, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
22nd Century Group Secures New Contract Manufacturing Agreements, Expands Distribution Network and Manufacturing Capabilities Ahead of VLN® Launch
Company will Increase Investment in Tobacco Production and Testing Equipment and Add New Talent in…
LIXTE BIOTECHNOLOGY COMMENTS ON REPORT THAT ITS PP2A INHIBITOR LB-100 COMBINED WITH ANOTHER INVESTIGATIONAL AGENT STIMULATES BONE GROWTH IN MODELS OF DWARFISM
Altadena, CA, July 22, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (Nasdaq:LIXTE) a clinical-stage…
Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor Claim
New twice-a-day dosing regimen allows for daily immune system support Company intends to create a…
Parexel Announces Innovative Partnership with Rare Disease Foundation in China
Collaboration with Beijing Illness Challenge Foundation seeks to empower patients and improve clinical trial experience…
Levitee Labs Provides Company Update Following CSE Listing
VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) — Levitee Labs Inc. (CSE: LVT) (the “Company” or “Levitee”) is pleased…
Innovation Pharmaceuticals Announces New In Vitro Data Supporting Brilacidin’s Broad-Spectrum Antiviral Potential Presented at the American Society of Virology’s Annual Meeting
Brilacidin showed potent inhibition in multiple human cell lines and in different strains of alphaviruses…
Radius Health Announces Plans for Global Prader-Willi Syndrome Pivotal Study
FDA Type C meeting minutes provide clarity on the Phase 2/3 study design for RAD011…
Athenex to Provide Corporate and Financial Update for the Second Quarter 2021 on August 5, 2021
BUFFALO, N.Y., July 22, 2021 (GLOBE NEWSWIRE) — Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical…
Rubius Therapeutics to Announce Second Quarter 2021 Financial Results
CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical…
Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue
EWING, N.J., July 22, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Intrado and ADT Partner to Enhance Emergency Response via Direct Data Messaging to 911 Communications Centers
America’s #1 smart home security provider leverages Intrado platform to quickly deliver human-verified data to…
Skullcandy Taps Channel Signal to Amp Up Its Reviews Landscape and Gain Critical Customer Insights
PARK CITY, Utah, July 22, 2021 (GLOBE NEWSWIRE) — Channel Signal, the leading aggregator of…
Onit CEO Eric M. Elfman Named an Honoree for the Houston Business Journal’s Most Admired CEO Awards
Eric M. Elfman, CEO and co-founder of Onit Onit co-founder and CEO Eric M. Elfman…
Datametrex Signs Four New Shows Through Mid-2022
Toronto, Ontario–(Newsfile Corp. – July 23, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G)…
Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma
TOKYO and KENILWORTH, N.J., Jul 23, 2021 – (JCN Newswire) – Eisai Co., Ltd. and…